New brain sensor tested during tumor removal
NCT ID NCT07465796
First seen Mar 27, 2026 · Last updated May 15, 2026 · Updated 6 times
Summary
This study tests a new device called CIPHER that helps surgeons map brain activity during tumor removal. Ten adults with newly diagnosed glioma will have the device used on their tumor and surrounding brain tissue during standard surgery. The main goals are to see if the device is safe and if it can record brain signals properly. Participants will be followed for six weeks after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Royal Melbourne Hospital, Department of Neurosurgery 4 East
Melbourne, Victoria, 3050, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.